Patents by Inventor Janet Chollet

Janet Chollet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9693953
    Abstract: The present invention provides novel pharmaceutical compositions containing triphenylethylene derivative compounds, and methods of using the composition for treatment of symptoms associated with atrophic vaginitis. The pharmaceutical compositions are prepared for the vaginal administration of triphenylethylene derivative compounds in single or combination therapies. Preferably, the triphenylethylene derivative is tamoxifen.
    Type: Grant
    Filed: June 4, 2007
    Date of Patent: July 4, 2017
    Inventors: Janet A. Chollet, Fred H. Mermelstein, Bernadette Klamerus
  • Patent number: 9675546
    Abstract: The present invention provides novel pharmaceutical compositions containing triphenylethylene derivative compounds, and methods of using the composition for treatment of symptoms associated with atrophic vaginitis. The pharmaceutical compositions are prepared for the vaginal administration of triphenylethylene derivative compounds in single or combination therapies. Preferably, the triphenylethylene derivative is tamoxifen.
    Type: Grant
    Filed: June 27, 2008
    Date of Patent: June 13, 2017
    Inventors: Bernadette Klamerus, Janet A. Chollet, Fred Mermelstein
  • Patent number: 9480662
    Abstract: The present invention provides topical compositions and methods for administering tamoxifen citrate while minimizing the incidence and or severity of adverse drug experiences associated with tamoxifen therapy. In one aspect, these compositions and methods provide a lower plasma concentration of tamoxifen metabolites, such as 4-hydroxytamoxifen and N-desmethyltamoxifen, which is presumed to be contributing at least in part to some of the adverse drug experiences, while maintaining sufficient tamoxifen as the sole active agent to benefit a subject with tamoxifen therapy.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: November 1, 2016
    Inventors: Janet A. Chollet, Fred H. Mermelstein
  • Publication number: 20090137538
    Abstract: This invention relates to a method and pharmaceutical composition useful in treating a condition responsive to hormone replacement therapy. Specifically, the invention is related to the long term treatment of symptoms associated with atrophic vaginitis. The composition contains effective amounts of an estrogen, a progesterone compound and a pharmaceutically accepted vehicle, carrier and/or diluent.
    Type: Application
    Filed: June 27, 2008
    Publication date: May 28, 2009
    Inventors: Bernadette Klamerus, Janet A. Chollet
  • Publication number: 20090092656
    Abstract: The present invention provides novel pharmaceutical compositions containing triphenylethylene derivative compounds, and methods of using the composition for treatment of symptoms associated with atrophic vaginitis. The pharmaceutical compositions are prepared for the vaginal administration of triphenylethylene derivative compounds in single or combination therapies. Preferably, the triphenylethylene derivative is tamoxifen.
    Type: Application
    Filed: June 27, 2008
    Publication date: April 9, 2009
    Inventors: Bernadette KLAMERUS, Janet A. Chollet, Fred Mermelstein
  • Publication number: 20080026035
    Abstract: The present invention provides novel pharmaceutical compositions containing triphenylethylene derivative compounds, and methods of using the composition for treatment of symptoms associated with atrophic vaginitis. The pharmaceutical compositions are prepared for the vaginal administration of triphenylethylene derivative compounds in single or combination therapies. Preferably, the triphenylethylene derivative is tamoxifen.
    Type: Application
    Filed: June 4, 2007
    Publication date: January 31, 2008
    Applicant: PEAR TREE WOMEN'S HEALTH CARE
    Inventors: Janet Chollet, Fred Mermelstein
  • Publication number: 20070264309
    Abstract: This invention relates to a method and pharmaceutical composition useful in treating a condition responsive to hormone replacement therapy. Specifically, the invention is related to the long term treatment of symptoms associated with atrophic vaginitis. The composition contains effective amounts of an estrogen, a progesterone compound and a pharmaceutically accepted vehicle, carrier and/or diluent.
    Type: Application
    Filed: January 22, 2007
    Publication date: November 15, 2007
    Inventors: Janet Chollet, Fred Mermelstein